INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 285 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,066,813 | -15.8% | 286,743 | +8.6% | 0.02% | -13.0% |
Q2 2023 | $10,771,195 | +32.7% | 264,110 | +21.3% | 0.02% | +21.1% |
Q1 2023 | $8,114,759 | +11.7% | 217,729 | +4.5% | 0.02% | 0.0% |
Q4 2022 | $7,266,575 | -38.6% | 208,271 | -1.5% | 0.02% | -40.6% |
Q3 2022 | $11,831,000 | +27.3% | 211,423 | +17.8% | 0.03% | +33.3% |
Q2 2022 | $9,292,000 | -15.7% | 179,525 | +18.3% | 0.02% | +100.0% |
Q1 2022 | $11,028,000 | +4.1% | 151,748 | +69.4% | 0.01% | -47.8% |
Q4 2021 | $10,592,000 | -43.2% | 89,581 | -35.6% | 0.02% | -51.1% |
Q3 2021 | $18,648,000 | +2.0% | 139,015 | +23.1% | 0.05% | -7.8% |
Q2 2021 | $18,279,000 | +104.6% | 112,902 | +1.4% | 0.05% | +64.5% |
Q1 2021 | $8,933,000 | +170.1% | 111,298 | +83.0% | 0.03% | +158.3% |
Q4 2020 | $3,307,000 | +348.1% | 60,802 | +63.9% | 0.01% | +200.0% |
Q3 2020 | $738,000 | +38.7% | 37,102 | +46.6% | 0.00% | +33.3% |
Q2 2020 | $532,000 | +178.5% | 25,307 | +61.6% | 0.00% | +200.0% |
Q1 2020 | $191,000 | -6.8% | 15,656 | +12.2% | 0.00% | 0.0% |
Q4 2019 | $205,000 | +45.4% | 13,954 | +32.3% | 0.00% | 0.0% |
Q3 2019 | $141,000 | – | 10,547 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |